Evidence map›Paper›PMID 22836211›Full record

ArticleMolecules (Basel, Switzerland)2012

Gastroprotection of suaveolol, isolated from Hyptis suaveolens, against ethanol-induced gastric lesions in Wistar rats: role of prostaglandins, nitric oxide and sulfhydryls.

Carlos Vera-Arzave, Leticia Cruz Antonio, Jesús Arrieta, Gerardo Cruz-Hernández, Antonio Magdiel Velasquez-Mendez, Adelfo Reyes-Ramírez, María Elena Sánchez-Mendoza

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. Traditional Uses, Phytochemistry, and Bioactivities ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Review
  2. Plants againstBiotechnology reports (Amsterdam, Netherlands) · 2020
    Review
  3. Article
  4. Gastroprotective Effects of Paeonia Extract Mixture HT074 against Experimental Gastric Ulcers in Rats.Evidence-based complementary and alternative medicine : eCAM · 2019
    Article
  5. Gastroprotective Activity ofMolecules (Basel, Switzerland) · 2018
    Article
  6. Review
  7. Review
  8. Article
  9. Cytoprotective and antioxidant effects of the methanol extract of Eremomastax speciosa in rats.African journal of traditional, complementary, and alternative medicines : AJTCAM · 2014
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Carlos Vera-ArzaveSuperior Medicine School, National Polytechnic Institute, Plan de San Luis y Díaz Mirón, Colonia Santo Tomás, Delegación Miguel Hidalgo, Mexico City 11340, Mexico.
Leticia Cruz Antonio
Jesús Arrieta
Gerardo Cruz-Hernández
Antonio Magdiel Velasquez-Mendez
Adelfo Reyes-Ramírez
María Elena Sánchez-Mendoza
Instituto Politécnico Nacional · MXUniversidad del Ejército y Fuerza Aérea · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyptis suaveolens is a medicinal plant that is, according to traditional medicine, considered useful in the treatment of gastric ulcers. Although its gastroprotective activity was reported, the active compounds have not been identified. Therefore, the aim of the present study was to identify at least one active compound potentially responsible for the gastroprotective activity of H. suaveolens by using a bioassay guided study with an ethanol-induced gastric ulcer experimental model in rats. The results show that the hexane extract had protective activity (close to 70% when using doses between 10 and 100 mg/kg), and that the compound suaveolol, isolated from this extract, was one of the active gastroprotective agents. This is the first report about the gastroprotective activity of suaveolol. Rats treated with this compound at 3, 10, 30 and 100 mg/kg showed 12.6, 21.3, 39.6 and 70.2% gastroprotection respectively. The effect elicited by suaveolol (at 100 mg/kg) was attenuated by pretreatment with either N(G)-nitro-L-arginine methyl ester (70 mg/kg, i.p.), a nitric oxide (NO) synthase inhibitor, indomethacin (10 mg/kg, s.c.), a blocker of prostaglandin synthesis, or N-ethylmaleimide (10 mg/kg, s.c.), a blocker of sulfhydryl groups. This suggests that the gastroprotective mechanism of action of this compound involves NO, prostaglandins and sulfhydryl groups.

Indexed as

AnimalsAnti-Ulcer AgentsCarbenoxoloneCyclooxygenase InhibitorsEthanolEthylmaleimideHyptisIndomethacinMaleMolecular StructureNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide SynthasePlant ExtractsPolycyclic CompoundsProstaglandinsAnti-Ulcer AgentsCarbenoxoloneCyclooxygenase InhibitorsEthanolEthylmaleimideIndomethacinNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide SynthasePlant ExtractsPolycyclic CompoundsProstaglandinssuaveololSulfhydryl CompoundsSulfhydryl Reagents

Identifiers

PMID22836211
PMCPMC6268582
OpenAlexW2076747199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.